163 related articles for article (PubMed ID: 26989119)
1. Enoxaparin and rivaroxaban have different effects on human mesenchymal stromal cells in the early stages of bone healing.
Pilge H; Fröbel J; Prodinger PM; Mrotzek SJ; Fischer JC; Zilkens C; Bittersohl B; Krauspe R
Bone Joint Res; 2016 Mar; 5(3):95-100. PubMed ID: 26989119
[TBL] [Abstract][Full Text] [Related]
2. Effects of thromboprophylaxis on mesenchymal stromal cells during osteogenic differentiation: an in-vitro study comparing enoxaparin with rivaroxaban.
Pilge H; Fröbel J; Mrotzek SJ; Fischer JC; Prodinger PM; Zilkens C; Bittersohl B; Krauspe R
BMC Musculoskelet Disord; 2016 Mar; 17():108. PubMed ID: 26927834
[TBL] [Abstract][Full Text] [Related]
3. The effect of a new direct Factor Xa inhibitor on human osteoblasts: an in-vitro study comparing the effect of rivaroxaban with enoxaparin.
Solayar GN; Walsh PM; Mulhall KJ
BMC Musculoskelet Disord; 2011 Oct; 12():247. PubMed ID: 22035050
[TBL] [Abstract][Full Text] [Related]
4. Does Anticoagulant Medication Alter Fracture-Healing? A Morphological and Biomechanical Evaluation of the Possible Effects of Rivaroxaban and Enoxaparin Using a Rat Closed Fracture Model.
Prodinger PM; Burgkart R; Kreutzer K; Liska F; Pilge H; Schmitt A; Knödler M; Holzapfel BM; Hapfelmeier A; Tischer T; Bissinger O
PLoS One; 2016; 11(7):e0159669. PubMed ID: 27455072
[TBL] [Abstract][Full Text] [Related]
5. Recurrence of malignancy-associated venous thromboembolism among patients treated with rivaroxaban compared to enoxaparin.
Nicklaus MD; Ludwig SL; Kettle JK
J Oncol Pharm Pract; 2018 Apr; 24(3):185-189. PubMed ID: 29284351
[TBL] [Abstract][Full Text] [Related]
6. Retrospective Evaluation of Postoperative Adverse Drug Events in Patients Receiving Rivaroxaban After Major Orthopedic Surgery Compared with Standard Therapy in a Community Hospital.
Cieri NE; Kusmierski K; Lackie C; Van Opdorp A; Hassan AK
Pharmacotherapy; 2017 Feb; 37(2):170-176. PubMed ID: 28028830
[TBL] [Abstract][Full Text] [Related]
7. Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study.
Alzghari SK; Seago SE; Garza JE; Hashimie YF; Baty KA; Evans MF; Shaver C; Herrington JD
J Oncol Pharm Pract; 2018 Oct; 24(7):494-500. PubMed ID: 28714376
[TBL] [Abstract][Full Text] [Related]
8. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.
Desai A; Desai A; Calixte R; Aparnath M; Hindenburg A; Salzman S; Mathew JP
Lung; 2016 Aug; 194(4):605-11. PubMed ID: 27192990
[TBL] [Abstract][Full Text] [Related]
9. A comparative study in patients with fractures of the lower limbs between rivaroxaban versus enoxaparin and its impact on bone healing time.
Peláez-Damy P; Torres-Gómez A; Mas-Celis F; Martínez-Villalobos M
Acta Ortop Mex; 2017; 31(4):177-181. PubMed ID: 29216693
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of rivaroxaban use in patients with gynecologic malignancies at an academic medical center: A pilot study.
Signorelli JR; Gandhi AS
J Oncol Pharm Pract; 2019 Mar; 25(2):362-368. PubMed ID: 29157146
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France, Italy and Spain.
Monreal M; Folkerts K; Diamantopoulos A; Imberti D; Brosa M
Thromb Haemost; 2013 Nov; 110(5):987-94. PubMed ID: 23965805
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the effects of Enoxaparin, Fondaparinux, and Rivaroxaban used in thromboembolism prophylaxis on fracture healing in rats.
Demirtas A; Azboy I; Bulut M; Ucar BY; Alabalik U; Necmioglu NS
Eur Rev Med Pharmacol Sci; 2013 Jul; 17(14):1850-6. PubMed ID: 23877846
[TBL] [Abstract][Full Text] [Related]
13. Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolism.
Wysokinski WE; Houghton DE; Casanegra AI; Vlazny DT; Bott-Kitslaar DM; Froehling DA; Hodge DO; Peterson LG; Mcbane RD
Am J Hematol; 2019 Nov; 94(11):1185-1192. PubMed ID: 31378995
[TBL] [Abstract][Full Text] [Related]
14. Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison.
Loke YK; Kwok CS
J Clin Pharm Ther; 2011 Feb; 36(1):111-24. PubMed ID: 21198726
[TBL] [Abstract][Full Text] [Related]
15. The Utility of Rivaroxaban as Primary Venous Thromboprophylaxis in an Adult Trauma Population.
Kingdon LK; Miller EM; Savage SA
J Surg Res; 2019 Dec; 244():509-515. PubMed ID: 31336243
[TBL] [Abstract][Full Text] [Related]
16. Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer's perspective.
Duran A; Sengupta N; Diamantopoulos A; Forster F; Kwong L; Lees M
J Med Econ; 2011; 14(6):824-34. PubMed ID: 22023098
[TBL] [Abstract][Full Text] [Related]
17. Use of prestudy heparin did not influence the efficacy and safety of rivaroxaban in patients treated for symptomatic venous thromboem-bolism in the EINSTEIN DVT and EINSTEIN PE studies.
Prandoni P; Prins MH; Cohen AT; Müller K; Pap ÁF; Tewes MC; Lensing AW
Acad Emerg Med; 2015 Feb; 22(2):142-9. PubMed ID: 25676529
[TBL] [Abstract][Full Text] [Related]
18. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
Ma G; Zhang R; Wu X; Wang D; Ying K
Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
[TBL] [Abstract][Full Text] [Related]
19. Rivaroxaban Versus Enoxaparin for Venous Thromboembolism Prophylaxis after Hip and Knee Arthroplasty.
Charters MA; Frisch NB; Wessell NM; Dobson C; Les CM; Silverton CD
J Arthroplasty; 2015 Jul; 30(7):1277-80. PubMed ID: 25724111
[TBL] [Abstract][Full Text] [Related]
20. A RCT study of Rivaroxaban, low-molecular-weight heparin, and sequential medication regimens for the prevention of venous thrombosis after internal fixation of hip fracture.
Tang Y; Wang K; Shi Z; Yang P; Dang X
Biomed Pharmacother; 2017 Aug; 92():982-988. PubMed ID: 28605879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
